Advertisement

Truly Frugal Pet: Is It Possible?

  • R. J. Nickles
  • O. T. de Jesus

Abstract

A pivotal issue in this post-election year concerns the containment of health care costs, currently absorbing about 14% of the GDP. This is clearly an inopportune time to promote a diagnostic technique at a seemingly staggering cost, for widespread public acceptance. This note addresses the question: must PET always be “big science”? (1) Our conclusion is simple: it needn’t be. With a realistic institutional self-perception, a hospital can chart a sensible course to contain the capital outlays and operating expenses for the in-house cyclotron, scanner and the oft-forgotten radiochemical facility that bridges production and the user. Only a few years ago, the target was to provide a $2 million PET center. Today, most new installations are requesting $5–10 million to start up from scratch, with promise of a three-year forgiveness before coming up to clinical speed. Staffing, service contracts and equipment amortization drive up the PET center’s operating budget toward a million dollars a year, necessitating thousands of thousand dollar scans per year to break even. No PET center in the world has even remotely approached this performance.

Keywords

White Dwarf Service Contract Direct Fluorination Tracer Metabolite Standard Good Manufacturing Practice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. Dyson, “From Eros to Gaia,” Pantheon Press, New York (1992).Google Scholar
  2. 2.
    R.J. Nickles, M.E. Daube, T.J. Ruth, An 18O2 target for the production of 18F2, Int. J. Appl. Rad Isotopes 35: 117(1984).CrossRefGoogle Scholar
  3. 3.
    O.T. de Jesus, D. Murali, R. Kitchen, T.R. Oakes, R.J. Nickles, Direct Synthesis of 3-Huoro-a-fluoromethyl-p-tyrosine, J Fluorine Chem (in press).Google Scholar
  4. 4.
    M.J. Adam and S. Jivan, Synthesis and Purification of L-6-[F-18]Fluorodopa, Int. J. Appl. Rad. Isotopes 39, 1203 (1988).Google Scholar
  5. 5.
    A. Luxen, M. Perlmutter, G.T. Bida, G.V. Moffaert, J.S. Cook, N. Satyamurthy, M.E. Phelps, J.R. Barrio, Remote, semiautomated production of 6-[F-18]-Fluoro-L-DOPA for human studies with PET, Int. J. Appl. Rad. Isotopes 41, 275 (1990).Google Scholar
  6. 6.
    J.R. Grierson and M.J. Adam, In-situ preparation of a chemically bonded chiral stationary phase for the separation of aromatic oc-amino acid enantiomers, J. Chromatog 325, 103 (1985).CrossRefGoogle Scholar
  7. 7.
    A. Luxen, J.R. Barrio, G.V. Moffaert, M. Perlmutter, J.C. Cook, M.E. Phelps, Remote, semiautomated production of 6-[F-18]Fluoro-L-DOPA for human studies with PET, J. Lab. Comp. Radiopharm. 26, 465 (1989).CrossRefGoogle Scholar
  8. 8.
    R.J. Nickles, O.T. de Jesus, O. Solin, M. Haaparanta-Solin, A flow-through detector for nanoCurie activities encountered in HPLC analysis of PET tracer metabolites, IEEE Trans. Nucl. Sci. 39, 2316 (1992).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • R. J. Nickles
    • 1
  • O. T. de Jesus
    • 1
  1. 1.Medical Physics DepartmentUniversity of WisconsinMadisonUSA

Personalised recommendations